dc.date.accessioned2022-01-18T19:26:52Z
dc.date.available2022-01-18T19:26:52Z
dc.date.created2022-01-18T19:26:52Z
dc.date.issued2011
dc.identifierhttps://hdl.handle.net/20.500.12866/10962
dc.identifierhttps://doi.org/10.1097/QCO.0b013e3283428d1e
dc.description.abstractPurpose of Review: Balamuthia mandrillaris infection of the skin and central nervous system has been increasingly reported in the last decade, making this entity a genuine emerging disease. The ability of the clinician in recognizing the skin lesion early in the course of the disease may lead to a successful therapeutic intervention in an otherwise fatal disease. RECENT FINDINGS: In the past years, advances have been made regarding knowledge about the ubiquity of the ameba in the environment, its worldwide distribution (with higher prevalence in South America), the patients at risk (particularly those of Hispanic origin), the diagnostic methods (including those based on molecular biology) and the different therapeutic strategies that have resulted in survival of patients. A recent report dealing with organ transplant transmission of this infection has made it a subject of interest in transplant medicine. SUMMARY: The present review will allow readers from different fields (clinician, dermatologist, neurologist, infectious disease and transplant specialist) to become familiar with the clinical aspect of the disease, including diagnosis and therapy.
dc.languageeng
dc.publisherWolters Kluwer Health
dc.relationCurrent Opinion in Infectious Diseases
dc.relation1473-6527
dc.rightshttps://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
dc.rightsinfo:eu-repo/semantics/restrictedAccess
dc.subjectHumans
dc.subjectPolymerase Chain Reaction
dc.subjectFever
dc.subjectHeadache
dc.subjectMortality
dc.subjectPyrrole Derivative
dc.subjectFlow Cytometry
dc.subjectSkin Biopsy
dc.subjectAlbendazole
dc.subjectSerology
dc.subjectSkin Defect
dc.subjectEnzyme Linked Immunosorbent Assay
dc.subjectAzithromycin
dc.subjectCotrimoxazole
dc.subjectImmunohistochemistry
dc.subjectFluconazole
dc.subjectMetronidazole
dc.subjectParomomycin
dc.subjectAmphotericin B
dc.subjectBrain Necrosis
dc.subjectAntiprotozoal Agents
dc.subjectMolecular Biology
dc.subjectMacrolide
dc.subjectIntracranial Hypertension
dc.subjectAmebiasis
dc.subjectArtesunate
dc.subjectBalamuthia Infection
dc.subjectBalamuthia Mandrillaris
dc.subjectClarithromycin
dc.subjectEncephalitis
dc.subjectInflammatory Infiltrate
dc.subjectItraconazole
dc.subjectMiltefosine
dc.subjectSkin Diseases Parasitic
dc.subjectTrophozoite
dc.subjectBrain Hemorrhage
dc.subjectFlucytosine
dc.subjectPhotophobia
dc.subjectPleocytosis
dc.subjectSulfadiazine
dc.subjectThioridazine
dc.subjectOrgan Transplantation
dc.subjectImmunocompromised Host
dc.subjectSeizure
dc.subjectAmeba
dc.subjectAmoeba
dc.subjectAnisocoria
dc.subjectBalamuthia
dc.subjectCentral Nervous System Protozoal Infections
dc.subjectCerebrospinal Fluid Cytology
dc.subjectComa
dc.subjectCommunicable Diseases Emerging
dc.subjectConsciousness Level
dc.subjectFace Injury
dc.subjectGranulomatous Inflammation
dc.subjectImmunofluorescence Test
dc.subjectIsethionic Acid
dc.subjectLethargy
dc.subjectMotor Dysfunction
dc.subjectPentamidine
dc.subjectSensory Dysfunction
dc.subjectSkin Lesion
dc.titleBalamuthia mandrillaris infection of the skin and central nervous system: An emerging disease of concern to many specialties in medicine
dc.typeinfo:eu-repo/semantics/review


Este ítem pertenece a la siguiente institución